Neurofibromatosis Type 1 with Neck and Thoraco-Abdominal Involvement: A Case Series Showing Different Localization and MRI Features

References

• Becker B, Strowd RE 3rd. Phakomatoses. Dermatol Clin. 2019;37(4):583–606. doi:10.1016/j.det.2019.05.015
   Web of Science ®Google Scholar
• Fortman BJ, Kuszyk BS, Urban BA, Fishman EK. Neurofibromatosis type 1: a diagnostic mimicker at CT. Radiographics. 2001;21(3):601–612. doi:10.1148/radiographics.21.3.g01ma05601
   Web of Science ®Google Scholar
• Ferner RE, Gutmann DH. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res. 2002;62(5):1573–1577.
   PubMed Web of Science ®Google Scholar
• Huson SM, Norton A. Neurofibromatosis types 1 and 2. In.: Genetic Predisposition to Cancer. Second ed. 2003:73–96. doi:10.1201/b13271-10
   Google Scholar
• Cimino PJ, Gutmann DH. Neurofibromatosis type 1. In: Handbook of Clinical Neurology, 1st ed. Elsevier B.V; 2018:148. doi:10.1016/B978-0-444-64076-5.00051-X
   Google Scholar
• Drouet A. Seizures in neurofibromatosis. What is the risk? Revue Neurologique. 2011;167(12):886–896. doi:10.1016/j.neurol.2011.04.009
   Web of Science ®Google Scholar
• Hekmatnia A, Ghazavi A, Shooshtari MJM, Hekmatnia F, Basiratnia R. Imaging review of neurofibromatosis: helpful aspects for early detection. Iranian J Radiol. 2011;8(2):63–74.
   Web of Science ®Google Scholar
• Legius E, Brems H. Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism. Childs Nerv Syst. 2020;36(10):2285–2295. doi:10.1007/s00381-020-04771-8
   Web of Science ®Google Scholar
• Ghalayani P, Saberi Z, Sardari F. Neurofibromatosis type 1 (von Recklinghausen's disease): a family case report and literature review. Dental Res J. 2012;9(4):483–488.
   Google Scholar
• Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genetics Med. 2010;12(1):1–11. doi:10.1097/GIM.0b013e3181bf15e3
   Web of Science ®Google Scholar
• Boyd KP, Korf BR, Theos A. NIH public access. J Am Acad Dermatol. 2009;61(1):1–16. doi:10.1016/j.jaad.2008.12.051
   PubMed Web of Science ®Google Scholar
• Available from: https://consensus.nih.gov/1987/1987Neurofibramatosis064html.htm. Accessed March 26, 2021.
   Google Scholar
• Ortonne N, Wolkenstein P, Blakeley JO, et al. Cutaneous neurofibromas: current clinical and pathologic issues. Neurology. 2018;91(2):S5–S13. doi:10.1212/WNL.0000000000005792
   Google Scholar
• Hassell DS, Bancroft LW, Kransdorf MJ, et al. Imaging appearance of diffuse neurofibroma. AJR Am J Roentgenol. 2008;190(3):582–588. doi:10.2214/AJR.07.2589
   Web of Science ®Google Scholar
• Liu Y, Jordan JT, Bredella MA, et al. Correlation between NF1 genotype and imaging phenotype on whole-body MRI: NF1 radiogenomics. Neurology. 2020;94(24):e2521–e2531. doi:10.1212/WNL.0000000000009490
   Web of Science ®Google Scholar
• Ghosh PS, Ghosh D. Teaching NeuroImages: MRI “target sign” and neurofibromatosis type 1. Neurology. 2012;78(9):899–900. doi:10.1212/WNL.0b013e318248df63
   Web of Science ®Google Scholar
• Ahlawat S, Blakeley JO, Langmead S, Belzberg AJ, Fayad LM. Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type (2), and schwannomatosis. Skeletal Radiology. 2020;49(2):199–219. doi:10.1007/s00256-019-03290-1
   Google Scholar
• Levy AD, Patel N, Dow N, Abbott RM, Miettinen M, Sobin LH. From the archives of the AFIP abdominal neoplasms in patients with neurofibromatosis Type 1: radiologic-pathologic correlation. RadioGraphics. 2005;25:455–480. doi:10.1148/rg.252045176
   Web of Science ®Google Scholar
• Meyer A, Billings SD. What’s new in nerve sheath tumors. Virchows Archiv. 2020;476(1):65–80. doi:10.1007/s00428-019-02671-0
   Web of Science ®Google Scholar
• Ahlawat S, Blakeley JO, Rodriguez FJ, Fayad LM. Imaging biomarkers for malignant peripheral nerve sheath tumors in neurofibromatosis type 1. Neurology. 2019;93(11):e1076–e1084. doi:10.1212/WNL.0000000000008092
   Web of Science ®Google Scholar
• Ahlawat S, Fayad LM, Khan MS, et al. Whole body MRI Committee for the REiNS International Collaboration; REiNS International Collaboration Members 2016. Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis. Neurology. 2016;87(7 Suppl 1):S31–9. doi:10.1212/WNL.0000000000002929
   Google Scholar
• Fayad LM, Blakeley J, Plotkin S, Widemann B, Jacobs MA. Whole body MRI at 3T with quantitative diffusion weighted imaging and contrast-enhanced sequences for the Characterization of peripheral lesions in patients with neurofibromatosis Type 2 and schwannomatosis. ISRN Radiol. 2013;2013:627932. doi:10.5402/2013/627932
   Google Scholar